| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9378(12)80031-7 |
| P698 | PubMed publication ID | 1384332 |
| P2093 | author name string | S Schwartz | |
| J A Canick | |||
| M G Blitzer | |||
| D N Saller | |||
| P2860 | cites work | Maternal serum screening for Down's syndrome in early pregnancy | Q35703368 |
| Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities | Q44259917 | ||
| Prenatal screening for trisomy 18 in the second trimester | Q67678252 | ||
| Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome | Q70056433 | ||
| An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities | Q72729435 | ||
| Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome | Q72730932 | ||
| P433 | issue | 4 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1021-1024 | |
| P577 | publication date | 1992-10-01 | |
| P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
| P1476 | title | Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome | |
| P478 | volume | 167 |
| Q73310744 | A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy |
| Q72095130 | A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol |
| Q34140689 | Advances in prenatal screening for Down syndrome: I. general principles and second trimester testing |
| Q71612161 | Detection of fetal Turner syndrome with multiple-marker screening |
| Q77802929 | Endocrine analytes in multiple-marker screening |
| Q44176247 | Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis |
| Q33768998 | First trimester screening for aneuploidy: serum biochemical markers |
| Q71753829 | Free beta hCG screening of hydropic and non-hydropic Turner syndrome pregnancies |
| Q50860489 | Maternal serum alpha-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome. |
| Q52078526 | Maternal serum free beta-hCG and PAPP-A in fetal sex chromosome defects in the first trimester. |
| Q71821372 | Multiple-marker screen positive results in Rubinstein-Taybi syndrome |
| Q51981098 | Prenatal diagnosis of trisomy 20 mosaicism by maternal serum screening for Down syndrome. |
| Q35171691 | Prenatal screening for Down syndrome: current and future methods |
| Q36754874 | Prenatal screening for fetal aneuploidy |
| Q33958921 | Prenatal screening for fetal aneuploidy in singleton pregnancies |
| Q44572511 | Quantitative trace analysis of estriol in human plasma by negative ion chemical ionization gas chromatography-mass spectrometry using a deuterated internal standard. |
| Q34356065 | Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement |
| Q51155567 | Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease. |
| Q42640640 | Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women |
| Q72089457 | Turner syndrome associated with an omphalocele |
| Q72064882 | Umbilical cord hernia, single umbilical artery, and lung hypoplasia in Ullrich‐Turner syndrome |
Search more.